Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction Scores

PromarkerD is a biomarker-based blood test that predicts kidney function decline in people with type 2 diabetes (T2D) who may otherwise be missed by current standard of care tests. This study examined the association between canagliflozin and change in PromarkerD score (Δ score) over a three-year pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Kirsten E., Bringans, Scott D., O’Neill, Ronan S., Lumbantobing, Tasha S. C., Lui, James K. C., Davis, Timothy M. E., Hansen, Michael K., Lipscombe, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179173/
https://www.ncbi.nlm.nih.gov/pubmed/37176686
http://dx.doi.org/10.3390/jcm12093247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179173/
https://www.ncbi.nlm.nih.gov/pubmed/37176686
http://dx.doi.org/10.3390/jcm12093247

Ejemplares similares